MINI FUTURE OPTIONSSCHEIN PUT - BIOGEN IDEC | Market Closed - Bid/Ask 15:34:35 2024-05-21 EDT | After market 15:59:44 | |||
| 14.04 EUR | +2.18% |
|
14.08 | +0.28% |
| Current month | -8.40% | ||
| 1 month | -18.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-21 | 14.04 | +2.18% |
| 24-05-20 | 13.74 | -0.51% |
| 24-05-17 | 13.81 | -0.43% |
| 24-05-16 | 13.87 | +3.66% |
| 24-05-15 | 13.38 | -5.91% |
Real-time Boerse Frankfurt Warrants
Last update May 21, 2024 at 03:34 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ7N60 |
| ISIN | DE000DJ7N609 |
| Date issued | 2023-12-15 |
| Strike | 378.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 11.06 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.84 € |
|---|---|
| Lowest since issue | 10.11 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
231.6
USD
Average target price
285.9
USD
Spread / Average Target
+23.47%
- Stock Market
- Certificates
- Certificat